The value of postoperative HLA-DR expression and high mobility group box 1 level in predictive diagnosis of sepsis in percutaneous nephrolithotomy surgery
暂无分享,去创建一个
[1] D. Shkarupa,et al. A Feasibility of Percutaneous Nephrolithotomy in Positive Urine Culture: A Single Center Retrospective Study. , 2020, Urology journal.
[2] Iekhsan Othman,et al. Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling. , 2019, European journal of pharmacology.
[3] T. Billiar,et al. Location is the key to function: HMGB1 in sepsis and trauma‐induced inflammation , 2019, Journal of leukocyte biology.
[4] M. Bauer,et al. Late Peaks of HMGB1 and Sepsis Outcome: Evidence for Synergy With Chronic Inflammatory Disorders. , 2019, Shock.
[5] B. Brumback,et al. Evidence for Persistent Immune Suppression in Patients Who Develop Chronic Critical Illness After Sepsis , 2017, Shock.
[6] E. Schwedhelm,et al. Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFα response: A diagnostic tool for immunosuppression? , 2017, PloS one.
[7] Sumit Suresh Bansal,et al. Predictive factors for fever and sepsis following percutaneous nephrolithotomy: A review of 580 patients , 2017, Urology annals.
[8] Hu Peng,et al. Dynamic monitoring of monocyte HLA-DR expression for the diagnosis, prognosis, and prediction of sepsis. , 2017, Frontiers in bioscience.
[9] A. Kirkpatrick,et al. High Mobility Group Box-1 Protein and Outcomes in Critically Ill Surgical Patients Requiring Open Abdominal Management , 2017, Mediators of inflammation.
[10] R. Bellomo,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[11] M. Menon,et al. Trends in percutaneous nephrolithotomy use and outcomes in the United States. , 2013, The Journal of urology.
[12] B. Kim,et al. Predictive Factors for Bleeding During Percutaneous Nephrolithotomy , 2013, Korean journal of urology.
[13] J. Timsit,et al. Inter‐laboratory assessment of flow cytometric monocyte HLA‐DR expression in clinical samples , 2013, Cytometry. Part B, Clinical cytometry.
[14] Michael Bauer,et al. New Approaches to Sepsis: Molecular Diagnostics and Biomarkers , 2012, Clinical Microbiology Reviews.
[15] R. Hotchkiss,et al. Immunosuppression in patients who die of sepsis and multiple organ failure. , 2011, JAMA.
[16] B. Allaouchiche,et al. Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma , 2010, Critical care.
[17] N. Unterwalder,et al. High-Mobility Group Box-1 Protein Serum Levels Do Not Reflect Monocytic Function in Patients with Sepsis-Induced Immunosuppression , 2010, Mediators of inflammation.
[18] F. Genel,et al. Monocyte HLA-DR expression as predictor of poor outcome in neonates with late onset neonatal sepsis. , 2010, The Journal of infection.
[19] R. Pirracchio,et al. Monocytic HLA‐DR expression in intensive care patients: Interest for prognosis and secondary infection prediction * , 2009, Critical care medicine.
[20] A. Ayala,et al. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock , 2007, Critical care medicine.
[21] Yasuhiro Yamamoto,et al. Relationship Between Effect of Polymyxin B–Immobilized Fiber and High-Mobility Group Box-1 Protein in Septic Shock Patients , 2007, ASAIO journal.
[22] Maurice Stephan Michel,et al. Complications in percutaneous nephrolithotomy. , 2007, European urology.
[23] B. Drénou,et al. Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock. , 2004, American journal of respiratory and critical care medicine.
[24] K. Tracey,et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[25] K. Tracey,et al. HMGB1 as a late mediator of lethal systemic inflammation. , 2001, American journal of respiratory and critical care medicine.
[26] M. Regan,et al. A systematic study of host defense processes in badly injured patients. , 1986, Annals of surgery.